Search

Anish Gupta

Examiner (ID: 17158)

Most Active Art Unit
1654
Art Unit(s)
1654, 1811, 6221, PCTL, IPLA, 1653
Total Applications
1025
Issued Applications
530
Pending Applications
179
Abandoned Applications
323

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5793999 [patent_doc_number] => 20060014680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Peptides and compounds that bind to the IL-5 receptor' [patent_app_type] => utility [patent_app_number] => 10/890546 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9231 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014680.pdf [firstpage_image] =>[orig_patent_app_number] => 10890546 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/890546
Peptides and compounds that bind to the IL-5 receptor Jul 12, 2004 Abandoned
Array ( [id] => 584656 [patent_doc_number] => 07438900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Dendritic encapsulation of active agents' [patent_app_type] => utility [patent_app_number] => 10/885878 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4549 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/438/07438900.pdf [firstpage_image] =>[orig_patent_app_number] => 10885878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885878
Dendritic encapsulation of active agents Jul 7, 2004 Issued
Array ( [id] => 5120511 [patent_doc_number] => 20070142226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof' [patent_app_type] => utility [patent_app_number] => 10/563637 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 35363 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142226.pdf [firstpage_image] =>[orig_patent_app_number] => 10563637 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/563637
Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof Jul 6, 2004 Abandoned
Array ( [id] => 6972263 [patent_doc_number] => 20050037973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Compounds and methods for cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/885482 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20018 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037973.pdf [firstpage_image] =>[orig_patent_app_number] => 10885482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885482
Compounds and methods for cancer therapy Jul 5, 2004 Abandoned
Array ( [id] => 7217980 [patent_doc_number] => 20050054818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Crystalline compositions for controlling blood glucose' [patent_app_type] => utility [patent_app_number] => 10/880884 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054818.pdf [firstpage_image] =>[orig_patent_app_number] => 10880884 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/880884
Crystalline compositions for controlling blood glucose Jun 29, 2004 Abandoned
Array ( [id] => 7265310 [patent_doc_number] => 20040242846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Method for the preparation of molecularly uniform hyperpolymeric hemoglobins' [patent_app_type] => new [patent_app_number] => 10/878724 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2780 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242846.pdf [firstpage_image] =>[orig_patent_app_number] => 10878724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/878724
Method for the preparation of molecularly uniform hyperpolymeric hemoglobins Jun 27, 2004 Abandoned
Array ( [id] => 7264928 [patent_doc_number] => 20040242464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin' [patent_app_type] => new [patent_app_number] => 10/876541 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9792 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242464.pdf [firstpage_image] =>[orig_patent_app_number] => 10876541 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/876541
Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin Jun 27, 2004 Abandoned
Array ( [id] => 7329787 [patent_doc_number] => 20040254115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator' [patent_app_type] => new [patent_app_number] => 10/865661 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14890 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254115.pdf [firstpage_image] =>[orig_patent_app_number] => 10865661 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/865661
Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator Jun 9, 2004 Issued
Array ( [id] => 7319591 [patent_doc_number] => 20040225120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Process for purifying a compound' [patent_app_type] => new [patent_app_number] => 10/863456 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10753 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225120.pdf [firstpage_image] =>[orig_patent_app_number] => 10863456 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863456
Process for purifying a compound Jun 7, 2004 Issued
Array ( [id] => 263776 [patent_doc_number] => 07569541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines' [patent_app_type] => utility [patent_app_number] => 10/559010 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7656 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569541.pdf [firstpage_image] =>[orig_patent_app_number] => 10559010 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559010
Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines Jun 1, 2004 Issued
Array ( [id] => 4999826 [patent_doc_number] => 20070042460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Oxidation of peptides' [patent_app_type] => utility [patent_app_number] => 10/558958 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1592 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042460.pdf [firstpage_image] =>[orig_patent_app_number] => 10558958 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558958
Oxidation of peptides May 27, 2004 Abandoned
Array ( [id] => 7297174 [patent_doc_number] => 20040214747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Method for administering monomeric insulin' [patent_app_type] => new [patent_app_number] => 10/852568 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7334 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214747.pdf [firstpage_image] =>[orig_patent_app_number] => 10852568 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852568
Method for administering monomeric insulin May 23, 2004 Abandoned
Array ( [id] => 582632 [patent_doc_number] => 07449443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Method for stabilization of proteins using non-natural amino acids' [patent_app_type] => utility [patent_app_number] => 10/851564 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10309 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449443.pdf [firstpage_image] =>[orig_patent_app_number] => 10851564 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851564
Method for stabilization of proteins using non-natural amino acids May 20, 2004 Issued
Array ( [id] => 7297232 [patent_doc_number] => 20040214781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same' [patent_app_type] => new [patent_app_number] => 10/851617 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5719 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214781.pdf [firstpage_image] =>[orig_patent_app_number] => 10851617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851617
Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same May 20, 2004 Abandoned
Array ( [id] => 7083797 [patent_doc_number] => 20050049177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Stable analogs of peptide and polypeptide therapeutics' [patent_app_type] => utility [patent_app_number] => 10/847220 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20931 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049177.pdf [firstpage_image] =>[orig_patent_app_number] => 10847220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/847220
Stable analogs of peptide and polypeptide therapeutics May 16, 2004 Issued
Array ( [id] => 5259886 [patent_doc_number] => 20070213518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel Lipolytic Enzyme Lip2' [patent_app_type] => utility [patent_app_number] => 10/555560 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14347 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213518.pdf [firstpage_image] =>[orig_patent_app_number] => 10555560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555560
Novel Lipolytic Enzyme Lip2 May 11, 2004 Abandoned
Array ( [id] => 7441635 [patent_doc_number] => 20040185539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols' [patent_app_type] => new [patent_app_number] => 10/472042 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4611 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185539.pdf [firstpage_image] =>[orig_patent_app_number] => 10472042 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/472042
Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols May 3, 2004 Abandoned
Array ( [id] => 7038939 [patent_doc_number] => 20050158373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Method and carrier complexes for delivering molecules to cells' [patent_app_type] => utility [patent_app_number] => 10/838135 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17255 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158373.pdf [firstpage_image] =>[orig_patent_app_number] => 10838135 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838135
Method and carrier complexes for delivering molecules to cells May 2, 2004 Issued
Array ( [id] => 4927883 [patent_doc_number] => 20080167246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative' [patent_app_type] => utility [patent_app_number] => 10/593352 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3305 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167246.pdf [firstpage_image] =>[orig_patent_app_number] => 10593352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593352
Ophthalmic and contact lens solutions containing peptides as preservative Apr 14, 2004 Issued
Array ( [id] => 4872688 [patent_doc_number] => 20080199422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline' [patent_app_type] => utility [patent_app_number] => 11/547926 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18069 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199422.pdf [firstpage_image] =>[orig_patent_app_number] => 11547926 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547926
Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline Apr 13, 2004 Abandoned
Menu